欧洲和北美少精症男性Y染色体微缺失患病率:系统综述与荟萃分析
结果显示,所有完整YCM均为AZFc微缺失,精子浓度≤1百万/ml者YCM患病率显著高于>1-5百万/ml者(5.0% vs 0.8%,p<0.001),而>1-5与>5-20百万/ml者无显著差异(p=0.14)。结论建议指南 reconsider 筛查阈值至<1百万/ml。
要点
- 少精症男性中完整YCM均为AZFc微缺失。
- 精子浓度≤1百万/ml者YCM患病率为5.0%,>1百万/ml者<1%。
- 建议仅对精子浓度<1百万/ml的男性进行YCM筛查。
核心结论
- 在欧洲和北美,大多数YCM发生在精子浓度≤1百万/ml的男性中,>1百万/ml者YCM识别率<1%。
- 男性不育指南应重新考虑YCM筛查的精子浓度阈值,建议仅对<1百万/ml者检测。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、EMBASE、Cochrane Library和ClinicalTrials.gov。
主要发现
- 所有完整YCM均为AZFc微缺失。
- 精子浓度>0-1百万/ml者YCM合并患病率为5.0%(95%CI:3.6-6.8%)。
- 精子浓度>1-5百万/ml者YCM合并患病率为0.8%(95%CI:0.5-1.3%),与>0-1百万/ml者相比p<0.001。
- 精子浓度>5-20百万/ml者YCM合并患病率为0.5%(95%CI:0.2-0.9%),与>1-5百万/ml者相比p=0.14。
关键数值与推荐
- 当前欧洲和北美指南推荐对无精症和精子浓度<5百万/ml的少精症男性进行YCM筛查。
- 本研究支持将筛查阈值调整为精子浓度<1百万/ml。
临床怎么用
- 临床对少精症男性进行YCM筛查时,应仅考虑精子浓度≤1百万/ml者,避免对>1百万/ml者常规筛查。
局限性
- 研究仅纳入欧洲和北美研究,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: European and North American guidelines recommend Y-chromosome microdeletion (YCM) screening in azoospermic and oligozoospermic men with sperm concentrations of <5 million sperm/ml; however, numerous studies have suggested that YCMs are rare when sperm concentrations are >1 million sperm/ml. OBJECTIVE: We systematically reviewed and meta-analyzed European and North American studies to determine the prevalence of a complete YCM in oligozoospermic men with sperm concentrations of >0-1, >1-5, and >5-20 million sperm/ml, and to determine whether 1 or 5 million sperm/ml is the most appropriate sperm concentration threshold for YCM screening. EVIDENCE ACQUISITION: A systematic review of MEDLINE, EMBASE, Cochrane Library, and ClinicalTrials.gov was performed for studies assessing the prevalence of a complete YCM in oligozoospermic men in European and North American studies. EVIDENCE SYNTHESIS: Thirty-seven studies were identified during a systematic review (n = 12 492 oligozoospermic men). All complete YCMs in oligozoospermic men were AZFc microdeletions. Eighteen studies contained data conducive to meta-analysis (n = 10 866 men). Comparing the pooled estimated prevalence by sperm concentration, complete YCMs were significantly more common in men with sperm concentrations of >0-1 million sperm/ml (5.0% [95% confidence interval {CI}: 3.6-6.8%]) versus >1-5 million sperm/ml (0.8% [95% CI: 0.5-1.3%], p < 0.001). YCMs were similar in men with sperm concentrations of >1-5 and >5-20 million sperm/ml (0.8% [95% CI: 0.5-1.3%] vs 0.5% [95% CI: 0.2-0.9%], p = 0.14). CONCLUSIONS: In Europe and North America, the majority of YCMs occur in men with sperm concentrations of ≤1 million sperm/ml, with <1% identified in men with >1 million sperm/ml. Male infertility guidelines for North America and Europe should reconsider the sperm concentration screening thresholds to recommend testing for YCMs only for men with sperm concentrations of <1 million sperm/ml. PATIENT SUMMARY: Complete Y-chromosome microdeletions (YCMs) are rare in men with >1 million sperm/ml. Routine screening for YCMs should occur only if sperm concentration is ≤1 million sperm/ml.
引用
- Kohn TP, Kohn JR, Owen RC, et al. The Prevalence of Y-chromosome Microdeletions in Oligozoospermic Men: A Systematic Review and Meta-analysis of European and North American Studies. Eur Urol. 2019. PMID: 31400948. doi:10.1016/j.eururo.2019.07.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。